Early research (Phase 1)Study completedNCT00092937
What this trial is testing
Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant
Who this might be right for
Granulomatous DiseaseChronic
National Institute of Allergy and Infectious Diseases (NIAID) 2